Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2013

Open Access 01-12-2013 | Research

Surgical decompression improves recovery from neurological deficit and may provide a survival benefit in patients with diffuse large B-cell lymphoma-associated spinal cord compression: a case-series study

Authors: Ching-Ming Chang, Hung-Chieh Chen, Youngsen Yang, Ren-Ching Wang, Wen-Li Hwang, Chieh-Lin Jerry Teng

Published in: World Journal of Surgical Oncology | Issue 1/2013

Login to get access

Abstract

Background

Malignancy-associated spinal cord compression is generally treated by surgical decompression, radiotherapy or a combination of both. Since diffuse large B-cell lymphoma (DLBCL) is highly sensitive to both chemotherapy and radiotherapy, the role of surgical decompression in the treatment of DLBCL-associated spinal cord compression remains unclear. We therefore conducted a retrospective review to investigate the impact of surgical decompression on recovery from neurological deficit caused by DLBCL-associated spinal cord compression and patients’ overall survival.

Methods

Between March 2001 and September 2011, 497 newly diagnosed DLBCL patients were reviewed, and 11 cases had DLBCL-associated spinal cord compression. Six cases were treated surgically and five cases nonsurgically.

Results

The rates of complete recovery from neurological deficit were 100% (6/6) and 20% (1/5) for patients in the surgical and nonsurgical groups, respectively (P = 0.015), while the median survival for patients in the surgical and nonsurgical groups was 48.6 months and 17.8 months, respectively (P = 0.177).

Conclusions

We conclude that surgical decompression can improve recovery from neurological deficit in patients with DLBCL-associated spinal cord compression, possibly providing these patients a survival benefit.
Literature
2.
go back to reference Ramadan KM, Shenkier T, Sehn LH, Gascoyne RD, Connors JM: A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol. 2007, 18: 129-135.CrossRefPubMed Ramadan KM, Shenkier T, Sehn LH, Gascoyne RD, Connors JM: A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol. 2007, 18: 129-135.CrossRefPubMed
3.
go back to reference Akram H, Allibone J: Spinal surgery for palliation in malignant spinal cord compression. Clin Oncol (R Coll Radiol). 2010, 22: 792-800. 10.1016/j.clon.2010.07.007.CrossRef Akram H, Allibone J: Spinal surgery for palliation in malignant spinal cord compression. Clin Oncol (R Coll Radiol). 2010, 22: 792-800. 10.1016/j.clon.2010.07.007.CrossRef
4.
go back to reference Coiffier B: Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma. Semin Oncol. 2002, 29: 18-22.CrossRefPubMed Coiffier B: Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma. Semin Oncol. 2002, 29: 18-22.CrossRefPubMed
5.
go back to reference Flowers CR, Sinha R, Vose JM: Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J Clin. 2010, 60: 393-408.PubMed Flowers CR, Sinha R, Vose JM: Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J Clin. 2010, 60: 393-408.PubMed
6.
go back to reference Peng X, Wan Y, Chen Y, Chen L, He A, Liao W, Shen J, Fu Q, Han S, Li F, Zou X: Primary non-Hodgkin's lymphoma of the spine with neurologic compression treated by radiotherapy and chemotherapy alone or combined with surgical decompression. Oncol Rep. 2009, 21: 1269-1275.CrossRefPubMed Peng X, Wan Y, Chen Y, Chen L, He A, Liao W, Shen J, Fu Q, Han S, Li F, Zou X: Primary non-Hodgkin's lymphoma of the spine with neurologic compression treated by radiotherapy and chemotherapy alone or combined with surgical decompression. Oncol Rep. 2009, 21: 1269-1275.CrossRefPubMed
7.
go back to reference Jaffe ES: The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009, 523-531. 10.1182/asheducation-2009.1.523. Jaffe ES: The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009, 523-531. 10.1182/asheducation-2009.1.523.
8.
go back to reference Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989, 7: 1630-1636.PubMed Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989, 7: 1630-1636.PubMed
9.
go back to reference Maynard FM, Bracken MB, Creasey G, Ditunno JF, Donovan WH, Ducker TB, Garber SL, Marino RJ, Stover SL, Tator CH, Waters RL, Wilberger JE, Young W: International standards for neurological and functional classification of spinal cord injury. American Spinal Injury Association. Spinal Cord. 1997, 35: 266-274. 10.1038/sj.sc.3100432.CrossRefPubMed Maynard FM, Bracken MB, Creasey G, Ditunno JF, Donovan WH, Ducker TB, Garber SL, Marino RJ, Stover SL, Tator CH, Waters RL, Wilberger JE, Young W: International standards for neurological and functional classification of spinal cord injury. American Spinal Injury Association. Spinal Cord. 1997, 35: 266-274. 10.1038/sj.sc.3100432.CrossRefPubMed
10.
go back to reference Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5: 649-655. 10.1097/00000421-198212000-00014.CrossRefPubMed Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5: 649-655. 10.1097/00000421-198212000-00014.CrossRefPubMed
11.
go back to reference Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45: 228-247. 10.1016/j.ejca.2008.10.026.CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45: 228-247. 10.1016/j.ejca.2008.10.026.CrossRefPubMed
12.
go back to reference A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993, 329: 987-994. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993, 329: 987-994.
13.
go back to reference Vanneuville B, Janssens A, Lemmerling M, de Vlam K, Mielants H, Veys EM: Non-Hodgkin's lymphoma presenting with spinal involvement. Ann Rheum Dis. 2000, 59: 12-14. 10.1136/ard.59.1.12.PubMedCentralCrossRefPubMed Vanneuville B, Janssens A, Lemmerling M, de Vlam K, Mielants H, Veys EM: Non-Hodgkin's lymphoma presenting with spinal involvement. Ann Rheum Dis. 2000, 59: 12-14. 10.1136/ard.59.1.12.PubMedCentralCrossRefPubMed
14.
go back to reference Cole JS, Patchell RA: Metastatic epidural spinal cord compression. Lancet Neurol. 2008, 7: 459-466. 10.1016/S1474-4422(08)70089-9.CrossRefPubMed Cole JS, Patchell RA: Metastatic epidural spinal cord compression. Lancet Neurol. 2008, 7: 459-466. 10.1016/S1474-4422(08)70089-9.CrossRefPubMed
15.
go back to reference Cabanillas F: Front-line management of diffuse large B cell lymphoma. Curr Opin Oncol. 2010, 22: 642-645. 10.1097/CCO.0b013e32833ed848.CrossRefPubMed Cabanillas F: Front-line management of diffuse large B cell lymphoma. Curr Opin Oncol. 2010, 22: 642-645. 10.1097/CCO.0b013e32833ed848.CrossRefPubMed
16.
go back to reference Phan J, Mazloom A, Jeffrey Medeiros L, Zreik TG, Wogan C, Shihadeh F, Rodriguez MA, Fayad L, Fowler N, Reed V, Horace P, Dabaja BS: Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol. 2010, 28: 4170-4176. 10.1200/JCO.2009.27.3441.CrossRefPubMed Phan J, Mazloom A, Jeffrey Medeiros L, Zreik TG, Wogan C, Shihadeh F, Rodriguez MA, Fayad L, Fowler N, Reed V, Horace P, Dabaja BS: Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol. 2010, 28: 4170-4176. 10.1200/JCO.2009.27.3441.CrossRefPubMed
17.
go back to reference Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, Harrop JS, Fehlings MG, Boriani S, Chou D, Schmidt MH, Polly DW, Biagini R, Burch S, Dekutoski MB, Ganju A, Gerszten PC, Gokaslan ZL, Groff MW, Liebsch NJ, Mendel E, Okuno SH, Patel S, Rhines LD, Rose PS, Sciubba DM, Sundaresan N, Tomita K, Varga PP, Vialle LR, Vrionis FD, Yamada Y, Fourney DR: A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine. 2010, 35: E1221-E1229. 10.1097/BRS.0b013e3181e16ae2.CrossRefPubMed Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, Harrop JS, Fehlings MG, Boriani S, Chou D, Schmidt MH, Polly DW, Biagini R, Burch S, Dekutoski MB, Ganju A, Gerszten PC, Gokaslan ZL, Groff MW, Liebsch NJ, Mendel E, Okuno SH, Patel S, Rhines LD, Rose PS, Sciubba DM, Sundaresan N, Tomita K, Varga PP, Vialle LR, Vrionis FD, Yamada Y, Fourney DR: A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine. 2010, 35: E1221-E1229. 10.1097/BRS.0b013e3181e16ae2.CrossRefPubMed
18.
go back to reference Popa C, Popa F, Grigorean VT, Onose G, Sandu AM, Popescu M, Burnei G, Strambu V, Sinescu C: Vascular dysfunctions following spinal cord injury. J Med Life. 2010, 3: 275-285.PubMedCentralPubMed Popa C, Popa F, Grigorean VT, Onose G, Sandu AM, Popescu M, Burnei G, Strambu V, Sinescu C: Vascular dysfunctions following spinal cord injury. J Med Life. 2010, 3: 275-285.PubMedCentralPubMed
19.
go back to reference Ramsey S, McIlhenny C: Evidence-based management of upper tract urolithiasis in the spinal cord-injured patient. Spinal Cord. 2011, 49: 948-954. 10.1038/sc.2011.50.CrossRefPubMed Ramsey S, McIlhenny C: Evidence-based management of upper tract urolithiasis in the spinal cord-injured patient. Spinal Cord. 2011, 49: 948-954. 10.1038/sc.2011.50.CrossRefPubMed
20.
go back to reference Gelis A, Stefan A, Colin D, Albert T, Gault D, Goossens D, Perrouin-Verbe B, Fattal C, Pelissier J, Coudeyre E: Therapeutic education in persons with spinal cord injury: a review of the literature. Ann Phys Rehabil Med. 2011, 54: 189-210. 10.1016/j.rehab.2011.03.004.CrossRefPubMed Gelis A, Stefan A, Colin D, Albert T, Gault D, Goossens D, Perrouin-Verbe B, Fattal C, Pelissier J, Coudeyre E: Therapeutic education in persons with spinal cord injury: a review of the literature. Ann Phys Rehabil Med. 2011, 54: 189-210. 10.1016/j.rehab.2011.03.004.CrossRefPubMed
21.
go back to reference Pfreundschuh M, Kuhnt E, Trumper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, Lopez-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N: CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol. 2011, 12: 1013-1022. 10.1016/S1470-2045(11)70235-2.CrossRefPubMed Pfreundschuh M, Kuhnt E, Trumper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, Lopez-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N: CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol. 2011, 12: 1013-1022. 10.1016/S1470-2045(11)70235-2.CrossRefPubMed
22.
go back to reference Rodrigues CA, Patah PA, Novis YA, Hosing C, de Lima M: The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settings. Curr Hematol Malig Rep. 2011, 6: 47-57. 10.1007/s11899-010-0075-5.CrossRefPubMed Rodrigues CA, Patah PA, Novis YA, Hosing C, de Lima M: The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settings. Curr Hematol Malig Rep. 2011, 6: 47-57. 10.1007/s11899-010-0075-5.CrossRefPubMed
Metadata
Title
Surgical decompression improves recovery from neurological deficit and may provide a survival benefit in patients with diffuse large B-cell lymphoma-associated spinal cord compression: a case-series study
Authors
Ching-Ming Chang
Hung-Chieh Chen
Youngsen Yang
Ren-Ching Wang
Wen-Li Hwang
Chieh-Lin Jerry Teng
Publication date
01-12-2013
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2013
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-11-90

Other articles of this Issue 1/2013

World Journal of Surgical Oncology 1/2013 Go to the issue